LB Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -82 | -85 | -81 | |
EBITDA | -18,972 | -11,386 | -3,475 | -5,216 |
EBIT | -19,054 | -11,471 | -3,556 | -5,294 |
Net Income | -19,054 | -11,472 | -3,556 | -5,088 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,322 | -18,143 | -3,373 | -5,595 |
Cash | 320,676 | 250,173 | 269,744 | 14,225 |
Basic Shares | 28,241 | 25,299 | 25,299 | 251 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -321 | |||
EBITDA | -24,883 | -63,010 | -1,445 | -12,194 |
EBIT | -25,204 | -63,101 | -1,449 | -12,196 |
Net Income | -25,205 | -63,102 | -6,275 | -14,348 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -35,260 | -53,821 | -12,119 | -2,728 |
Cash | 250,173 | 22,978 | 14,979 | 21,404 |
Basic Shares | 25,299 | 3,539 | 3,540 | 3,540 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.67 |
2025-12-31 | -$0.45 |
2025-09-30 | -$0.61 |
2025-06-30 | -$1.44 |